This will become increasingly valuable as genomic sequencing gets cheaper. It's great that it's open source, and I hope researchers start submitting new SNPs (and other mutations) that they find.
Not licensed commercial though...
This will become increasingly valuable as genomic sequencing gets cheaper. It's great that it's open source, and I hope researchers start submitting new SNPs (and other mutations) that they find.
Not licensed commercial though...